U.S. Capital Wealth Advisors’s Boston Scientific BSX Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$316K	Sell	5,033 -19	-0.4%	-$1.52K	0.01%	809
2025 Q4	$482K	Buy	5,052 +46	+0.9%	+$4.51K	0.01%	666
2025 Q3	$489K	Buy	5,006 +477	+11%	+$49.4K	0.01%	642
2025 Q2	$486K	Buy	4,529 +326	+8%	+$33K	0.01%	603
2025 Q1	$424K	Buy	4,203 +480	+13%	+$48.3K	0.01%	621
2024 Q4	$333K	Buy	3,723 +829	+29%	+$73K	0.01%	659
2024 Q3	$243K	Sell	2,894 -498	-15%	-$39.3K	0.01%	634
2024 Q2	$261K	Sell	3,392 -529	-13%	-$38.7K	0.01%	592
2024 Q1	$269K	Sell	3,921 -769	-16%	-$49.4K	0.01%	587
2023 Q4	$271K	Sell	4,690 -411	-8%	-$21.9K	0.01%	575
2023 Q3	$269K	Sell	5,101 -196	-4%	-$10.3K	0.01%	546
2023 Q2	$287K	Buy	5,297 +532	+11%	+$27.8K	0.01%	544
2023 Q1	$238K	Buy	4,765 +821	+21%	+$38.7K	0.01%	579
2022 Q4	$182K	Buy	+3,944	New	+$171K	0.01%	624

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

U.S. Capital Wealth Advisors's BSX Position: Q1 2026 in Review

U.S. Capital Wealth Advisors reduced its Boston Scientific (BSX) stake by 0.38% in Q1 2026, selling an estimated $1.52K and leaving 5,033 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #809.

U.S. Capital Wealth Advisors first reported a position in BSX in Q4 2022 and has held it in 14 quarters since. The position peaked at $489K in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

U.S. Capital Wealth Advisors held 5,033 shares of Boston Scientific worth $316K as of Q1 2026.
U.S. Capital Wealth Advisors sold 19 Boston Scientific shares in Q1 2026, an estimated $1.52K.
Boston Scientific made up 0.01% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #809 holding.
U.S. Capital Wealth Advisors first reported a position in Boston Scientific in Q4 2022 and has held it in 14 quarters since.
U.S. Capital Wealth Advisors's Boston Scientific position peaked at $489K in Q3 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.